4//SEC Filing
Lu Timothy K 4
Accession 0001854270-25-000013
CIK 0001854270other
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 7:01 PM ET
Size
10.2 KB
Accession
0001854270-25-000013
Insider Transaction Report
Form 4
Lu Timothy K
DirectorCEO and Interim PFO and PAO
Transactions
- Award
Stock Option (Right to Buy)
2025-03-06+1,927,073→ 1,927,073 totalExercise: $3.97Exp: 2034-12-19→ Common Stock (1,927,073 underlying) - Award
Common Stock
2025-03-07+642,358→ 724,440 total
Holdings
- 52,839(indirect: By Spouse)
Common Stock
- 52,839(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The shares reported in this transaction represent restricted stock units ("RSUs") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan, as amended and restated (the "Amended and Restated Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from March 7, 2025, subject to the reporting person's continued service through the applicable vesting date.
- [F2]The shares are held by Luminen Services, LLC, as trustee of the Luminen Trust, of which the reporting person is the settlor. The reporting person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
- [F3]The option grant was approved by the Issuer's board of directors on December 20, 2024, subject to shareholder approval of the Amended and Restated Plan, under which the option was granted. The Issuer's shareholders approved the Amended and Restated Plan on March 6, 2025.
- [F4]Three-forty-eighth of the shares underlying this option vest on March 31, 2025 ("Vesting Commencement Date") and thereafter one-forty-eighth of the shares underlying this option vest in equal monthly installments from the Vesting Commencement Date, such that the option will be fully vested on the date forty-five months after the Vesting Commencement Date, subject to the reporting person's continued service through the applicable vesting date.
Documents
Issuer
Senti Biosciences, Inc.
CIK 0001854270
Entity typeother
Related Parties
1- filerCIK 0001852301
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 7:01 PM ET
- Size
- 10.2 KB